Elan has been a great stock over the last 8 years. I believe it is in the top 50 or so stocks for total return 1990 - 1997 (IBD). It tends to split at the 50+ level but hasn't yet. The company has a very good growth rate that I believe is accelerating (last quarter was +40% income +80% revenues). It is targeting $1 billion revenue by 2001 (currently $600 million) but could likely exceed that. I have seen analysts claim that it has a terrific drug pipeline that rivals competitors 10 times larger but I am not entirely sure of this. It does have some good potential drugs in the pipeline. The company has been on an acquisition binge of late and has continued to grow the company. I think the Neurex acquisition will be great and it will probably buy Sheffield in the future and start a pulmonary drug division with it. Hope this helps. Any corrections if needed?